AI Agent Operational Lift for Harrison/star in New York, New York

Why AI matters at this scale

Harrison & Star is a New York-based healthcare advertising agency founded in 1986, employing 201-500 people. It specializes in creating promotional campaigns for pharmaceutical, biotech, and medical device brands—a niche demanding scientific accuracy, regulatory compliance, and creative flair. At this size, the agency is large enough to invest in enterprise AI tools but nimble enough to implement them without the inertia of a mega-network.

The AI imperative for mid-market agencies

Mid-sized agencies face margin pressure from both holding company giants and nimble boutiques. AI offers a path to differentiate through speed, personalization, and data-driven insights. For Harrison & Star, AI can automate labor-intensive tasks like versioning ads for different audiences, analyzing campaign performance, and ensuring compliance—freeing up talent for high-value strategic work. With 200-500 employees, the agency has sufficient data and workflow complexity to justify AI, yet can avoid the integration nightmares of larger firms.

Three concrete AI opportunities with ROI

1. Generative AI for creative production
Deploy tools like Midjourney or Adobe Firefly to generate initial concepts, storyboards, and copy variants. This can cut the creative development cycle by 40-50%, allowing the agency to pitch more ideas and respond faster to client briefs. ROI: reduced overtime, faster time-to-market, and higher win rates.

2. AI-driven media buying and optimization
Integrate programmatic platforms with AI algorithms that adjust bids, audiences, and creatives in real time. For healthcare campaigns targeting physicians or patients, AI can optimize across endemic sites, social media, and connected TV. Expected uplift: 15-25% improvement in cost-per-engagement, directly attributable to client budgets.

3. Automated compliance and MLR review
Healthcare advertising requires medical-legal-regulatory (MLR) approval, a notorious bottleneck. AI can pre-screen content against FDA guidelines, flag off-label claims, and suggest compliant alternatives. This reduces review cycles from weeks to days, accelerating campaign launches and lowering the risk of costly regulatory actions.

Deployment risks for this size band

Mid-market agencies often lack dedicated AI/ML engineers, so reliance on third-party vendors is high. This introduces risks around data security, especially with sensitive patient or prescriber data. Change management is another hurdle: creatives may resist AI, fearing job displacement. A phased approach with clear communication and upskilling is critical. Finally, regulatory compliance in pharma means any AI-generated content must be rigorously validated—automation cannot replace human oversight entirely. Agencies must establish governance frameworks to audit AI outputs and maintain trust with healthcare clients.